Glucagon-like peptide-1 augments insulin-mediated glucose uptake in the obese state

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 8, 2002, Pages 3768-3773

  Egan, Josephine M ^a   Meneilly, Graydon S ^b   Habener, Joel F ^c   Elahi, Dariush ^a,d  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HUMAN INSULIN; INSULIN;

ADULT; ARTICLE; BODY MASS; CALCULATION; CONTROLLED STUDY; FEMALE; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HUMAN; INSULIN BLOOD LEVEL; INSULIN INFUSION; INSULIN RESISTANCE; MALE; MEASUREMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL;

EID: 0036342717     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.8.8743     Document Type: Article

References (37)

1. The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects
2. Antidiabetogenic effect of glucagon-like peptide-1 [7-36 amide] in normal subjects and patients with diabetes
3. Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal
4. Enteral enhancement of glucose disposition by both insulin-dependent and insulin-independent processes. A physiological role of glucagon-like peptide I
5. Insulinotropic hormone glucagon- like peptide-1-(7-37) appears not to augment insulin-mediated glucose uptake in young men during euglycemia
6. Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes
7. GLP-1 does not acutely affect insulin sensitivity in healthy man
8. Effect of glucagon-like peptide 1(7-36)-amide on glucose effectiveness and insulin action in people with type 2 diabetes mellitus
9. Effect of glucagon-like peptide 1 on non-insulin-mediated glucose uptake in the elderly patient with diabetes
10. Glucagon-like peptide-1 (7-37) augments insulin-mediated glucose uptake in elderly patients with diabetes
11. Report of the expert committee on the diagnosis and classification of diabetes mellitus
12. Influences of glucose loading and of injected insulin on hepatic glucose output
13. Effects of arterial versus venous sampling on analysis of glucose kinetics in man
14. Manual feedback technique for control of glucose concentration
15. 3H]-glucose infusion, and labelled or unlabelled glucose infusates
16. Impaired insulin secretion and increased insulin sensitivity in familial maturity-onset diabetes of the young 4 (insulin promoter factor-1 gene)
17. Critical variables in the radioimmunoassay of serum insulin using the double antibody technique
18. Insulin control of glucose metabolism in man: A new kinetic analysis
19. Measurement and validation of non-steady turnover rates with application to the insulin and glucose systems
20. Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon-like peptide-1 receptor
21. Effects of glucagon-like peptide (7-36 amide) on glucose kinetics during somatostatin-induced supression of insulin secretion in healthy men
22. Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitus
23. Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs
24. Glucagon-like peptide-1 has no insulin-like effects in insulin-dependent diabetic dogs maintained normoglycemic and normoinsulinemic
25. Extrapancreatic action of truncated glucagon-like peptide-I in Otsuka Long-Evans Tokushima fatty rats, an animal model for non-insulin-dependent diabetes mellitus
26. Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-I receptor
27. Absence of insulinotropic glucagoni-like peptide-I (7-37) receptors on isolated rat liver hepatocytes
28. Tissue-specific and glucose-dependent expression of receptor genes for glucagon and glucagon-like peptide-1 (GLP-1)
29. Functinonal expression of the rat glucagon-like peptide-1 receptor, evidence for coupling to both adenylyl cyclase and phospholipase-C
30. Glucagon-like peptide-1 binding to rat hepatic membranes
31. Glucagon-like peptide 1: A potent glycogenic hormone
32. Exendin-4 agonist and exendin (9-39)amide antagonist of the GLP-1(7-36) amide effects in liver and muscle
33. Glucagon-like peptide-1(7-36) amide and glycogen synthesis in the liver
34. Potent glycogenic effect of GLP-1 (7-36) in rat skeletal muscle
35. Failure of GLP-1(7-36)amide to affect glycogenesis in rat skeletal muscle
36. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like-receptor